Immix Biopharma, INC. (IMMX) SEC Filings — 2026
6 SEC filings for Immix Biopharma, INC. (IMMX) in 2026.
Filings
- Immix Biopharma Files Annual Report for 2025 — ARS · Apr 6, 2026
- Immix Biopharma, INC. 8-K Filing — 8-K · Mar 30, 2026
- Immix Biopharma Files S-8 for Employee Stock Plans — S-8 · Mar 25, 2026
- Immix Biopharma Files 8-K on Material Definitive Agreement — 8-K · Mar 25, 2026
- Immix Biopharma Files 424B5 Prospectus for Potential Offering — 424B5 · Mar 25, 2026
- Immix Biopharma's NXC-201 Shows 75% Complete Response in AL Amyloidosis Trial — 10-K · Mar 25, 2026